|
Product complaint # (b)(4).Date sent to the fda: 9/14/2026.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon, or its employees that the report constitutes an admission that the product, ethicon, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device lot, and no non-conformances were identified.Additional information was requested, the following was obtained:
could you please provide the lot #?
does a fragment of the needle remain in the patient¿s tissue? no ,as per our report details.Please read our report.If yes, was more than half the needle retained in the patient? is there any plan in place to remove the needle piece in the future?
if yes, could you please provide the scheduled date for the removal?
in which tissue structure was the broken needle located?
what is the surgeon's opinion of the potential consequences for the patient? no harm reported
to date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.
|